In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 215.2 | 200.8 | 239.3 | 185.3 | 126.5 | 92.3 | 79.2 | 74.2 |
Interest income on investments | 15.5 | 14.0 | 16.3 | 10.7 | 6.2 | 5.4 | 4.0 | 3.3 |
| 231.3 | 217.1 | 262.4 | 199.8 | 134.3 | 98.3 | 83.6 | 78.1 |
Interest expense: |
Interest on deposits | 41.5 | 69.2 | 125.6 | 78.5 | 37.5 | 19.8 | 12.9 | 10.6 |
| 145.4 | 227.5 | 396.4 | 251.3 | 42.9 | 23.5 | 15.6 | 12.3 |
Net interest income | 179.4 | 137.9 | 127.1 | 113.4 | 91.4 | 74.8 | 68.0 | 65.8 |
Provision for loan losses | | | | | -0.6 | 0.8 | 0.0 | 10.2 |
Net interest income after provision for loan losses | 179.4 | 137.9 | 127.1 | 113.4 | 92.0 | 74.0 | 67.9 | 55.7 |
Deposit and loan fees | | | | | | | 0.6 | 0.6 |
Other non-interest income | 58.6 | 57.2 | 52.8 | 47.9 | 47.0 | 46.5 | 34.8 | 30.9 |
Total non-interest income | 58.6 | 57.2 | 52.8 | 47.9 | 47.0 | 46.5 | 35.5 | 31.5 |
Non-interest expenses | 344.2 | 288.6 | 259.4 | 230.8 | 205.6 | 180.2 | 153.0 | 64.3 |
Pre-tax income before non-recurring items | 90.7 | 52.6 | 68.7 | 60.2 | 47.5 | 38.0 | 33.4 | 22.9 |
Non-recurring items | | | | -0.2 | | -3.7 | | |
Pre-tax income | 90.7 | 52.6 | 68.7 | 60.4 | 47.5 | 41.7 | 33.4 | 22.9 |
Income taxes | 12.6 | 7.4 | 8.5 | 5.9 | 9.5 | 13.0 | 10.9 | 7.0 |
Tax rate | 13.9% | 14.1% | 12.3% | 9.8% | 20.0% | 31.3% | 32.6% | 30.4% |
Net income | 65.7 | 37.4 | 54.4 | 52.3 | 38.0 | 28.6 | 22.5 | 15.9 |
Net margin | 27.6% | 19.1% | 30.3% | 32.4% | 27.3% | 23.8% | 21.7% | 18.3% |
|
Basic EPS | $2.10 | $1.32 | $1.95 | $1.90 | $1.38 | $1.04 | $0.81 | $0.56 |
Diluted EPS | $2.02 | $1.30 | $1.89 | $1.81 | $1.32 | $1.01 | $0.80 | $0.55 |
|
Shares outstanding (basic) | 31.3 | 28.3 | 27.9 | 27.6 | 27.6 | 27.6 | 27.8 | 28.6 |
Shares outstanding (diluted) | 32.5 | 28.7 | 28.8 | 28.8 | 28.7 | 28.4 | 28.2 | 29.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |